ピロニダール疾患に生じたマージョリン潰瘍:症例報告と歴史的考察
Paige Curcio1, Frank Ross2,3
1NYU Grossman School of Medicine, 550 1st Ave, New York, NY 10016, United States.
Journal of surgical case reports
|December 30, 2025
まとめ
ピロニダール疾患を有する若年女性に、まれなマージョリン潰瘍として現れる悪性転化が発生した。治癒しない潰瘍における生検の欠如による診断の遅れは、迅速な評価とフォローアップの必要性を強調している。
科学分野:
- 腫瘍学
- 皮膚科学
- 外科病理学
背景:
- ピロニダール疾患はまれに悪性転化を起こすことがある。
- マージョリン潰瘍は、ピロニダール疾患に関連する慢性創傷の既知の合併症である。
- 慢性創傷における悪性転化の診断の遅れは、進行した疾患につながる可能性がある。
研究 の 目的:
- ピロニダール疾患を有する若年女性における悪性転化のまれな症例を報告する。
- 治癒しない潰瘍における診断の課題と生検の重要性を強調する。
- 患者のフォローアップのためのシステムレベルのプロセスの改善の必要性を強調する。
主な方法:
- 慢性臀部潰瘍を有する若年女性の症例報告。
- 臨床所見、生検および画像検査を含む診断ワークアップ。
- 扁平上皮癌(SCC)の組織病理学的確認および転移性浸潤の評価。
主要な成果:
- 患者はピロニダール疾患に続発する全層潰瘍を呈した。
- 生検により扁平上皮癌(SCC)が確認された。
- 画像検査と吸引細胞診により、鼠径リンパ節へのSCC転移が明らかになり、疾患は切除不能と判断された。
結論:
- ピロニダール疾患における悪性転化は、まれであるが重要な考慮事項である。
- 早期診断と管理のためには、治癒しない潰瘍の迅速な生検が不可欠である。
- 切除不能な転移性SCCに対して全身療法が開始された。
関連する概念動画
Inflammatory Bowel Disease V: Surgical Management
420
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
420
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.1K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K
Peptic Ulcer Disease I: Introduction
704
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
704
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
502
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
502
Peptic Ulcer Disease II: Pathophysiology
1.8K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.8K
Inflammatory Bowel Disease I: Ulcerative Colitis
844
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
844
